Market pulse › Pharma and healthcare

Pharma and healthcare

Topic tag · tracked since 24 Sept · also pharma, pharmaceuticals, pharmaceutical, drugmakers

Filter Top stories

Today19 stories · 30 articles57 stories since 24 Sept

Net tone● −7% today+4% over the week

Market checkPharma −0.10%Nifty Pharma on Fri, 25 Sept · Nifty +0.34%

Developing2 storylinesBiggest: Fortis forensic audit in Daiichi dispute · 4 updates

Pharma and healthcare in three lines

Written 53m ago from its latest stories

Sun Pharma secured exclusive worldwide rights to Lerodalcibib, excluding the US and China
Morepen Laboratories submitted its first ANDA to USFDA for Sitagliptin Tablets
Dr Reddy's shares gained over 1% after Nomura retained its Buy rating

Stories per day

Bar colour is the day’s tone · tracking began on 24 Sept

1124 Sept

2125 Sept

726 Sept

527 Sept

1328 Sept

Often tagged with

stories together this week · colour is their tone

Hospitals9 USFDA7 Eli Lilly4 Novo Nordisk4 Fortis Healthcare3 Health insurance3 Insurance3 Sun Pharma3 Supreme Court3 AI2

Stories

57 in all · newest first

Order win▲ bullishLupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mLLupin received USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mLLupin USFDA1 source
54m

Broker call▲ bullishDr Reddy's shares gain over 1% after Nomura retains 'Buy'; Rs1,740 target, key biologics milestones aheadDr Reddy's CDMO1 source
1h

Broker call● mixedShrikant Chouhan recommends buying Torrent Pharma, selling Bharti AirtelBharti Airtel1 source
1h

▲ bullishMorepen Laboratories submits first ANDA to USFDA for Sitagliptin TabletsMorepen Laboratories submitted its first ANDA to USFDA for Sitagliptin TabletsMorepen Laboratories USFDA1 source
1h

Deal● mixedSun Pharma shares in focus after global licensing deal for cholesterol drug; check detailsSun Pharma1 source
2h

Deal▲ bullishSun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc.Sun Pharma secured exclusive rights to commercialize and manufacture Lerodalcibep worldwide, excluding the US and ChinaSun Pharma China2 sources
42m

Market move● mixedSun Pharma Share Price Live Updates: Sun Pharma Stock DetailsSun Pharma1 source
2h

Market move● mixedDivis Labs Share Price Live Updates: Divis Labs Stock UpdateDivi's Labs1 source
2h

Market move● mixedDr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows three-month performance declineDr Reddy's1 source
3h

Market move● mixedCipla Share Price Live Updates: Cipla's 3-Month PerformanceCipla1 source
3h

Market move● mixedApollo Hospital Share Price Live Updates: Apollo Hospital sees a decrease in weekly returnsApollo Hospitals Hospitals1 source
3h

Policy● mixedGovt, private hospitals likely to be graded on quality & safetyNiti Aayog is developing a national quality framework for public and private hospitalsHospitals2 sources
2h

Policy● mixedCDSCO steps up scrutiny of pharma drugs containing narcotic substancesCDSCO is addressing regulatory gaps around illegal diversion of pharmaceutical drugs containing narcotic substances1 source
10h

● mixedIndian-origin executives in demand to helm C-suite AI strategy globallyHoneywell Aerospace, Boeing, GE Healthcare and others have created chief AI and data officer rolesAI Boeing1 source
14h

Legal● mixedFortis says independent audit will establish non-involvement in Singh brothers’ share transfersSupreme Court cleared the way for an independent forensic audit of the share transfersFortis Healthcare Supreme Court Singh brothers2 sources
14h

Legal● mixedFortis confident of clean chit from audit in Singh brothers’ disputeFortis expects a clean chit from the audit in the Singh brothers’ disputeFortis Healthcare Supreme Court Hospitals1 source
16h

Data● mixedCompanies offering healthcare benefits see 13% drop in chronic claims, says reportCompanies offering healthcare benefits saw a 13% drop in chronic claimsInsurance Health insurance Star Health and Allied Insurance1 source
17h

Expansion● mixedPB Health’s hospital expansion plans on track: PB Fintech Chairman and Group CEOPB Fintech Hospitals Paytm1 source
18h

Policy● mixedFood safety vs public health: Maharashtra FDA chief Tukaram Mundhe calls for behaviour changeMaharashtra FDA chief Tukaram Mundhe said food and beverage choices should be considered when assessing illnessMaharashtra FMCG and consumption1 source
1d

Deal▲ bullishDr Lal PathLabs’ arm acquires 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs’ arm acquired an 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs Ghana Hospitals1 source
2d

Legal● mixedRs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly oppose a Kerala High Court petition seeking government intervention to lower breast cancer drug pricesNovartis India Eli Lilly1 source
2d

▲ bullishZydus Lifesciences’ New Jersey office clears USFDA inspection with no observationsUSFDA inspection concluded with nil observationsZydus Lifesciences USFDA2 sources
2d

● mixedUS FDA approves AbbVie's drug for Parkinson's diseaseUSFDA1 source
2d

Policy● mixedUS FDA approves Mirum's drug for rare bone disorderUSFDA1 source
2d

IPO● mixedVirtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: SourcesHRV Pharma is preparing for an IPO, with a draft prospectus likely in H1 2027Listing rules Startups and VC1 source
2d

IPO● mixedAdarx Pharma shares surge 30% in Nasdaq debut after upsized $446.3 million IPOWall Street2 sources
3d

Policy● mixedPharma PLI attracts over Rs 46,700 crore investments, but China still dominates API importsChina Manufacturing Trade and tariffs1 source
3d

Policy● mixedNPS Swasthya from 1 October: What you need to know about the new pension option and health coverNPS Swasthya combines retirement savings with healthcare benefits and mandatory super top-up health insuranceHealth insurance Insurance1 source
3d

● mixedHealth Care Roundup: Market TalkThe roundup covers healthcare-market commentary on Novartis, UCB and othersNovartis India1 source
3d

Policy● mixedBefore Ayushman Bharat, families sold their homes to afford treatment: J P NaddaJ P Nadda said Ayushman Bharat has transformed India’s healthcare1 source
3d

Expansion● mixedLord’s Mark advances AI breast cancer screening towards clinical trialsLord’s Mark and C-MET are advancing AI breast cancer screening towards clinical trialsAI1 source
3d

Funding and debt● mixedNIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.Federal research funding cuts delayed a clinical trial for children with DIPG, a deadly brain tumor1 source
3d

Expansion● mixedNovo is betting on its next chapter as Eli Lilly gains more ground in GLP-1sAnalysts say Lilly may have advantages as Novo tries to regain ground in the obesity drug marketEli Lilly Novo Nordisk1 source
3d

Expansion▲ bullishMax Healthcare expands Africa footprint with new centre in TanzaniaMax Healthcare opened a patient assistance centre in Dar es Salaam, TanzaniaMax Healthcare Hospitals Tanzania1 source
3d

Deal● mixedNanexa shares surge on €1.17 billion Novo Nordisk licensing dealNanexa shares more than doubled after announcing the drug-delivery licensing dealNovo Nordisk2 sources
3d

Legal▼ bearishSupreme Court allows independent forensic audit of Fortis transactions in Daiichi disputeThe Supreme Court declined to interfere with Delhi High Court orders allowing the auditFortis Healthcare Daiichi Sankyo Supreme Court6 sources
20h

● mixedThe Peptide Boom That Isn’t About Your MusclesThe opportunity is pill-form peptides that could challenge big pharma’s most profitable franchisesNovo Nordisk Eli Lilly1 source
3d

Deal● mixedAfter capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaringNovo Nordisk struck a licensing deal worth over $1 billionNovo Nordisk Eli Lilly European markets1 source
3d

Broker call● mixedWhat Should You Buy? Analysts took fresh bets on these stocks this week; Check targetsBrokerages initiated fresh coverage across retail broking, healthcare services, e-commerce and capital marketsStockbrokers Retail Hospitals1 source
3d

Market move▲ bullishOn a healthy note! FPIs return to healthcare, pour ₹15,800 cr since JulyHealthcare drew ₹2,114 crore in FPI inflows in the first half of September, the most of any sectorFII flows Hospitals1 source
3d

Show 17 more